Clinical research is hard. We’re here to help make your work easier. Here’s some ways in which we’ve helped our customers succeed.
Together, we’re on a mission
Whether you’re working on the next breakthrough treatment, or a small team bringing big innovation to the industry, Medable is here for you every step of the way.
What clients are saying
Medable hired a third-party firm to get real feedback from customers across our trials. Here’s what they had to say about us.
Better compliance and faster study startup
A top-10 pharmaceutical company chose Medable to “reach a broader patient population” and found success in “increasing per-protocol data collection compliance” and “significantly reducing participant recruitment time.”
Increased oversight and scalability with eCOA and eConsent
A pharmaceutical group sought to overcome regulatory barriers and chose Medable for their “reliable DCT platform.” They found success in “increased scalability, simplified clinical trial experience, and better oversight.”
Greater insights paired with an easy to use system
A top-10 pharmaceutical company sought Medable to improve its participant engagement achieved “streamlined user experience, aggregated data for greater insights, and seamless integration into participants lives.”
Optimizing choice, flexibility and outcomes with Patient-First Data Collection for Oncology
Download our latest case study to see how the Medable platform helped a top 5 global pharma company with a strong Oncology focus improve clinician oversight of patients between site visits.
“Our sites AND our teams are happy to report increased efficiency, reductions in ‘back and forth communication’, and less data entry.”
Top 5 Pharma
The latest from Medable
Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices
Industry experts from Medable and Harvard School of Medicine discuss how to equip your future digital/decentralized trial IRB & ethics submissions for success.
Rapid evolution: How DCT’s DNA became standard in modern clinical trials
It’s impossible to deny how different clinical trials look almost four years after the pandemic revolutionized clinical research. Today, the digital and decentralized tools and technologies that enabled clinical trials to carry on through the COVID-19 pandemic are present (in some form) in nearly all clinical trials, a far cry from the dynamics of 2019.
The Definitive Guide to Digital Evidence Generation
According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. Sparked by the COVID-19 pandemic of 2020, the rapid ascent of patient-centered technology and the digital and decentralized trials they’ve spawned has forever changed the landscape of clinical conduct. Sponsors are increasingly turning to DCT platforms in alignment with the rise of Life Science and Software-as-a-Service (SaaS) solutions. For those who haven't made the jump yet, there are many questions, including "What is a decentralized clinical trial?" Find out with this in-depth guide to decentralized clinical trials. Uncover how they work, their benefits, and how they transform clinical development.
Medable Wins 2023 Prix Galien Award for Best Digital Health Solution
Medable was awarded ‘Best Digital Health Solution’ from a field of 24 nominees at the Prix Galien USA Forum in New York City. This recognition underscores the impact of Medable’s evidence generation platform on clinical research worldwide.
Medable Partners with Pluto Health to Optimize Patient Experience and Improve Access to Clinical Trials
This strategic partnership combines best-in-class patient care coordination service and clinical trialsplatform to streamline execution, improve data quality, and enhance patient experience.
Medable Ranks in Top 8% of 2023 Inc. 5000 List of America’s Fastest-Growing Private Companies
Medable, the leading technology provider for patient-centric clinical trials, today announced that it ranked in the top 8 percent (#398) and was one of the top 50 software companies on the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. Medable’s ranking was fueled by its strong three-year growth rate of 1,453% from 2019 through 2022.